Expert Opinion on Drug Metabolism & Toxicology, Volume 20, Issue 3 (2024)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Drug Metabolism & Toxicology, Volume 20, Issue 3 (2024)

See all volumes and issues
Volume 20, 2024 Vol 19, 2023 Vol 18, 2022 Vol 17, 2021 Vol 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Editorial

Editorial
What is the impact of metabolic dysfunction–associated steatotic liver disease on drug transport and metabolism?
Christoph G. Dietrich & Andreas Geier
Pages: 107-110
Published online: 04 Mar 2024
First Page PreviewforWhat is the impact of metabolic dysfunction–associated steatotic liver disease on drug transport and metabolism? | Full Text | References | PDF (902.5 KB) | EPUB
  • 345 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Special Report

Report
How can we optimize the use of methotrexate to treat pediatric patients with inflammatory skin diseases?
Kajetan Kiełbowski, Estera Bakinowska & Andrzej Pawlik
Pages: 111-118
Published online: 04 Mar 2024
AbstractforHow can we optimize the use of methotrexate to treat pediatric patients with inflammatory skin diseases? | Full Text | References | PDF (337.7 KB) | EPUB
  • 99 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
Cannabidiol: metabolism and clinical efficacy in epileptic patients
Giovanni Battista Dell’Isola, Alberto Verrotti, Miriam Sciaccaluga, Gianluca Dini, Pietro Ferrara, Lucilla Parnetti & Cinzia Costa
Pages: 119-131
Published online: 12 Mar 2024
AbstractforCannabidiol: metabolism and clinical efficacy in epileptic patients | Full Text | References | PDF (375.7 KB) | EPUB
  • 113 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
A comprehensive update on the ADMET considerations for α2δ calcium channel ligand medications for treating restless legs syndrome
Gaia Pellitteri, Salvatore Versace, Giovanni Merlino, Annacarmen Nilo, Gian Luigi Gigli & Mariarosaria Valente
Pages: 133-142
Published online: 15 Mar 2024
AbstractforA comprehensive update on the ADMET considerations for α2δ calcium channel ligand medications for treating restless legs syndrome | Full Text | References | PDF (393 KB) | EPUB
  • 60 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Drug interactions of carbonic anhydrase inhibitors and activators
Claudiu T. Supuran
Pages: 143-155
Published online: 11 Mar 2024
AbstractforDrug interactions of carbonic anhydrase inhibitors and activators | Full Text | References | PDF (407.1 KB) | EPUB
  • 121 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Research

Article
Exploring the level of agreement among different drug-drug interaction checkers: a comparative study on direct oral anticoagulants
Massimo Carollo, Salvatore Crisafulli, Francesco Ciccimarra, Giuseppe Andò, Igor Diemberger & Gianluca Trifirò
Pages: 157-164
Published online: 27 Feb 2024
AbstractforExploring the level of agreement among different drug-drug interaction checkers: a comparative study on direct oral anticoagulants | Full Text | References | PDF (2.3 MB) | EPUB | Supplemental
  • 141 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Hepatotoxicity of newer antiseizure medications in children: an overview and disproportionality analysis of VigiBase
Sanja Petrović, Milena Kovačević, Sandra Vezmar Kovačević & Branislava Miljković
Pages: 165-173
Published online: 28 Feb 2024
AbstractforHepatotoxicity of newer antiseizure medications in children: an overview and disproportionality analysis of VigiBase | Full Text | References | PDF (508.1 KB) | EPUB
  • 159 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles